期刊文献+

Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy 被引量:12

Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
下载PDF
导出
摘要 Background: Gross target volume of primary tumor(GTV?P) is very important for the prognosis prediction of patients with nasopharyngeal carcinoma(NPC), but it is unknown whether the same is true for locally advanced NPC patients treated with intensity?modulated radiotherapy(IMRT). This study aimed to clarify the prognostic value of tumor volume for patient with locally advanced NPC receiving IMRT and to ind a suitable cut?of value of GTV?P for prognosis prediction.Methods: Clinical data of 358 patients with locally advanced NPC who received IMRT were reviewed. Receiver oper?ating characteristic(ROC) curves were used to identify the cut?of values of GTV?P for the prediction of diferent end?points [overall survival(OS), local relapse?free survival(LRFS), distant metastasis?free survival(DMFS), and disease?free survival(DFS)] and to test the prognostic value of GTV?P when compared with that of the American Joint Committee on Cancer T staging system.Results: The 358 patients with locally advanced NPC were divided into two groups by the cut?of value of GTV?P as determined using ROC curves: 219(61.2%) patients with GTV?P ≤46.4 mL and 139(38.8%) with GTV?P >46.4 mL. The 3?year OS, LRFS, DMFS, and DFS rates were all higher in patients with GTV?P ≤46.4 mL than in those with GTV?P > 46.4 mL(all P < 0.05). Multivariate analysis indicated that GTV?P >46.4 mL was an independent unfavorable prognostic factor for patient survival. The ROC curve veriied that the predictive ability of GTV?P was superior to that of T category(P < 0.001). The cut?of values of GTV?P for the prediction of OS, LRFS, DMFS, and DFS were 46.4, 57.9, 75.4 and 46.4 mL, respectively.Conclusion: In patients with locally advanced NPC, GTV?P >46.4 mL is an independent unfavorable prognostic indi?cator for survival after IMRT, with a prognostic value superior to that of T category. Background: Gross target volume of primary tumor(GTV-P) is very important for the prognosis prediction of patients with nasopharyngeal carcinoma(NPC), but it is unknown whether the same is true for locally advanced NPC patients treated with intensity-modulated radiotherapy(IMRT). This study aimed to clarify the prognostic value of tumor volume for patient with locally advanced NPC receiving IMRT and to ind a suitable cut-of value of GTV-P for prognosis prediction.Methods: Clinical data of 358 patients with locally advanced NPC who received IMRT were reviewed. Receiver oper-ating characteristic(ROC) curves were used to identify the cut-of values of GTV-P for the prediction of diferent end-points [overall survival(OS), local relapse-free survival(LRFS), distant metastasis-free survival(DMFS), and disease-free survival(DFS)] and to test the prognostic value of GTV-P when compared with that of the American Joint Committee on Cancer T staging system.Results: The 358 patients with locally advanced NPC were divided into two groups by the cut-of value of GTV-P as determined using ROC curves: 219(61.2%) patients with GTV-P ≤46.4 mL and 139(38.8%) with GTV-P 〉46.4 mL. The 3-year OS, LRFS, DMFS, and DFS rates were all higher in patients with GTV-P ≤46.4 mL than in those with GTV-P 〉 46.4 mL(all P 〈 0.05). Multivariate analysis indicated that GTV-P 〉46.4 mL was an independent unfavorable prognostic factor for patient survival. The ROC curve veriied that the predictive ability of GTV-P was superior to that of T category(P 〈 0.001). The cut-of values of GTV-P for the prediction of OS, LRFS, DMFS, and DFS were 46.4, 57.9, 75.4 and 46.4 mL, respectively.Conclusion: In patients with locally advanced NPC, GTV-P 〉46.4 mL is an independent unfavorable prognostic indi-cator for survival after IMRT, with a prognostic value superior to that of T category.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2016年第12期725-734,共10页
基金 supported by the National Natural Science Foundation of China (No.81372792)
关键词 Nasopharyngeal carcinoma Intensity-modulated radiotherapy Gross target volume of primary tumor PROGNOSIS Nasopharyngeal carcinoma Intensity-modulated radiotherapy Gross target volume of primary tumor Prognosis
  • 相关文献

参考文献1

二级参考文献13

  • 1Lartigau E, Guichard M. Does tirapazamine (SR-4233) have any cytotoxic or sensitizing effect on three human tumour cell lines at clinically relevant partial oxygen pressure? [J]. Int J Radiat Biol, 1995,67(2) :211-216.
  • 2Zhang M, Stevens G. Effect of radiation and tirapazamine (SR- 4233) on three melanoma cell line [J]. Melanoma Res, 1998,8 (6) :510-515.
  • 3Lambin P, Guichard M, Chavaudra N, et al. The effect of the hypoxie cell drug SR-4233 alone or combined with the ionizing radiations on two human tumor cell lines having differen radiosensitivity [J]. Radiother Oncol, 1992,24(3) :201-204.
  • 4Zaman K, Ryu H, Hall D, et al. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxiainducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21 (waf1/cip1), and erythropoietin [J]. J Neurosci, 1999,19(22):9821-9830.
  • 5Erler JT, Cawthorue C J, Williams KJ, et al. Hypoxia-mediated down-regulation of bid and bax in tumors occurs via hypoxiainducible factor 1-dependent and-independent mechanisms and contributes to drug resistance [J]. Mol Cell Biol, 2004,24(7): 2875-2889.
  • 6Wakisaka N, Kondo S, Yoshizaki T, et al. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxiainducible factor 1α [J]. Mol Cell Biol, 2004,24(12):5223- 5234.
  • 7Kondo S, Seo SY, Yoshizaki T, et al. EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells [J]. Cancer Res, 2006,66 (20) : 9870-9877.
  • 8Zhu Y, Denhardt DT, Cao H. Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a ras-activated enhancer [J]. Oncogene, 2005,24(43) :6555-6563.
  • 9Le QT, Sutphin PD, Rayehaudhufi S, et al. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas [J]. Clin Cancer Res, 2003,9 (1) : 59-67.
  • 10Masunaga S, Ono K, Hori H, et al. Effects of bioreductive agents tirapazamine and mitomycin C, on quiescent cell populations in solid tumors, evaluated by micronucleus assay [J]. Jpn J Cancer Res, 1997,88(9):907-14.

共引文献12

同被引文献68

引证文献12

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部